BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25501825)

  • 1. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
    Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models.
    Hao X; Bahia RK; Cseh O; Bozek DA; Blake S; Rinnenthal J; Weyer-Czernilofsky U; Rudolph D; Artee Luchman H
    Neuro Oncol; 2023 May; 25(5):913-926. PubMed ID: 36521007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2-p53 mediate a miR-181c-3p/LIF axis to regulate low dose-rate radiation-induced DNA damage in human B lymphocytes.
    Chen Y; Gong Y; Qin H; Wei S; Wei Y; Yu Y; Lin X; Shuai P; Wang T; Guo C; Wang Q; Li G; Meng L; Yi L
    Ecotoxicol Environ Saf; 2024 Jan; 270():115848. PubMed ID: 38134636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b/p53 axis.
    Biamonte F; Battaglia AM; Zolea F; Oliveira DM; Aversa I; Santamaria G; Giovannone ED; Rocco G; Viglietto G; Costanzo F
    Cell Death Dis; 2018 Dec; 9(12):1174. PubMed ID: 30518922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA 3928 Suppresses Glioblastoma through Downregulation of Several Oncogenes and Upregulation of p53.
    Mulcahy EQX; Zhang Y; Colόn RR; Cain SR; Gibert MK; Dube CJ; Hafner M; Abounader R
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and Mdm2 act synergistically to maintain cardiac homeostasis and mediate cardiomyocyte cell cycle arrest through a network of microRNAs.
    Stanley-Hasnain S; Hauck L; Grothe D; Aschar-Sobbi R; Beca S; Butany J; Backx PH; Mak TW; Billia F
    Cell Cycle; 2017; 16(17):1585-1600. PubMed ID: 28745540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.
    Zhou L; Tian Y; Guo F; Yu B; Li J; Xu H; Su Z
    Cancer Immunol Immunother; 2020 May; 69(5):835-846. PubMed ID: 32062693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function.
    Hauck PM; Wolf ER; Olivos DJ; Batuello CN; McElyea KC; McAtarsney CP; Cournoyer RM; Sandusky GE; Mayo LD
    Mol Cancer Res; 2017 Nov; 15(11):1598-1607. PubMed ID: 28784612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer.
    Huang YT; Cheng AC; Tang HC; Huang GC; Cai L; Lin TH; Wu KJ; Tseng PH; Wang GG; Chen WY
    Cell Death Dis; 2021 Sep; 12(10):880. PubMed ID: 34580281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-147b is an oncomiR acting synergistically with HIPK2 to promote pancreatic carcinogenesis.
    Wang G; Ma Z; Song C; Wang X; Zhou Z
    Cell Signal; 2023 Nov; 111():110840. PubMed ID: 37543099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myc overexpression brings out unexpected antiapoptotic effects of miR-34a.
    Sotillo E; Laver T; Mellert H; Schelter JM; Cleary MA; McMahon S; Thomas-Tikhonenko A
    Oncogene; 2011 Jun; 30(22):2587-94. PubMed ID: 21297663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designed novel nuclear localizing anticancer peptide targets p53 negative regulator MDM2 protein.
    Mukherjee N; Bhunia D; Garai PK; Mondal P; Barman S; Ghosh S
    J Pept Sci; 2024 Jan; 30(1):e3535. PubMed ID: 37580909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells.
    Madrigal T; Ortega-Bernal D; Herrera LA; González-De la Rosa CH; Domínguez-Gómez G; Aréchaga-Ocampo E; Díaz-Chávez J
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signals from the Metastatic Niche Regulate Early and Advanced Ovarian Cancer Metastasis through miR-4454 Downregulation.
    Dasari S; Pandhiri T; Grassi T; Visscher DW; Multinu F; Agarwal K; Mariani A; Shridhar V; Mitra AK
    Mol Cancer Res; 2020 Aug; 18(8):1202-1217. PubMed ID: 32350057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS induces lung tumorigenesis through microRNAs modulation.
    Shi L; Middleton J; Jeon YJ; Magee P; Veneziano D; Laganà A; Leong HS; Sahoo S; Fassan M; Booton R; Shah R; Crosbie PAJ; Garofalo M
    Cell Death Dis; 2018 Feb; 9(2):219. PubMed ID: 29440633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2- an indispensable player in tumorigenesis.
    Zafar A; Khan MJ; Naeem A
    Mol Biol Rep; 2023 Aug; 50(8):6871-6883. PubMed ID: 37314603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel evidence for retinoic acid-induced G (Rig-G) as a tumor suppressor by activating p53 signaling pathway in lung cancer.
    Sun J; Wang X; Liu W; Ji P; Shang A; Wu J; Zhou H; Quan W; Yao Y; Yang Y; Gu C; Sun Z; Goel A; Weng W; Li D
    FASEB J; 2020 Sep; 34(9):11900-11912. PubMed ID: 32741018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death-associated protein kinase 1 phosphorylates MDM2 and inhibits its protein stability and function.
    Zhang M; Shui X; Zheng X; Lee JE; Mei Y; Li R; Tian Y; Zheng X; Wang Q; Wang L; Chen D; Zhang T; Kim BM; Kim J; Lee TH
    Arch Pharm Res; 2023 Dec; 46(11-12):882-896. PubMed ID: 37804415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF500 abolishes breast cancer proliferation and sensitizes chemotherapy by stabilizing P53 via competing with MDM2.
    Ma X; Fan M; Yang K; Wang Y; Hu R; Guan M; Hou Y; Ying J; Deng N; Li Q; Jiang G; Zhang Y; Zhang X
    Cancer Sci; 2023 Nov; 114(11):4237-4251. PubMed ID: 37700392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.